SULFASALAZINE tablet Stati Uniti - Ingliż - NLM (National Library of Medicine)

sulfasalazine tablet

bryant ranch prepack - sulfasalazine (unii: 3xc8guz6cb) (sulfasalazine - unii:3xc8guz6cb) - sulfasalazine tablets are indicated: a) in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis; and b) for the prolongation of the remission period between acute attacks of ulcerative colitis. sulfasalazine tablets are contraindicated in: patients with intestinal or urinary obstruction, patients with porphyria as sulfonamides have been reported to precipitate an acute attack, patients hypersensitive to sulfasalazine, its metabolites, sulfonamides, or salicylates. none reported.

SALAZOPYRIN EN Iżrael - Ingliż - Ministry of Health

salazopyrin en

pfizer pfe pharmaceuticals israel ltd - sulfasalazine - tablets enteric coated - sulfasalazine 500 mg - sulfasalazine - sulfasalazine - for active rheumatoid arthritis which is not controlled by antiinflammatory drugs.ulcerative colitis, crohn's disease, pyoderma gangrenosum.

SALAZOPYRIN Iżrael - Ingliż - Ministry of Health

salazopyrin

pfizer pfe pharmaceuticals israel ltd - sulfasalazine - tablets - sulfasalazine 500 mg - sulfasalazine - sulfasalazine - treatment of ulcerative colitis and crohn's disease.

Sulfasalazine 250mg/5ml Oral Suspension Malta - Ingliż - Medicines Authority

sulfasalazine 250mg/5ml oral suspension

p & d pharmaceuticals limited - sulfasalazine - oral suspension - sulfasalazine 250 mg/5ml - antidiarrheals, intestinal antiinflammatory/antiinfective agents

Sulfasalazine Oral Suspension 250mg/5ml Malta - Ingliż - Medicines Authority

sulfasalazine oral suspension 250mg/5ml

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - sulfasalazine - oral suspension - sulfasalazine 250 mg/5ml - antidiarrheals, intestinal antiinflammatory/antiinfective agents